Rapidata
Rapidata supplies on-demand human feedback for training and evaluating AI models.
$8.5MSeed
LeadCP
Canaan Partners
Activity from announced rounds
Activity in this selectionEurope · Seed
Canaan Partners is an investment firm whose company directory identifies Draig Therapeutics and Solstice Oncology.
Recorded funding activity
Draig develops neuropsychiatric medicines, while Solstice advances an engineered CTLA-4 antibody for cancer treatment. The recorded history also includes Actualyze AI’s enterprise gateway for model access, request security, budgets and routing. Named regional funds retain separate identities.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $8.5M 1 disclosed · full round size, not this investor’s share